|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.150 CNY | 0.00% |
|
+1.78% | +0.59% |
| 29/07 | Jointown Pharmaceutical Plans Up to 2.2-Billion-Yuan Factoring | MT |
| 16/07 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| Market Cap | 2.57TCr 380.18Cr 330.49Cr 307.61Cr 282.43Cr 533.34Cr 36TCr 541.6Cr 3.63TCr 1.42TCr 18TCr 1.43TCr 1.4TCr 61TCr | P/E 2026 * |
11x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.14TCr 316.21Cr 274.88Cr 255.85Cr 234.91Cr 443.6Cr 30TCr 450.47Cr 3.02TCr 1.18TCr 15TCr 1.19TCr 1.16TCr 50TCr | EV / Sales 2026 * |
0.13x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.06% | Yield 2027 * | 4.33% |
| 1 week | +1.78% | ||
| Current month | +9.81% | ||
| 1 month | +9.81% | ||
| 3 months | -0.39% | ||
| 6 months | -3.20% | ||
| Current year | +0.59% |
| 1 week | 4.95 |  | 5.17 |
| 1 month | 4.69 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Hua Gong
CEO | Chief Executive Officer | 48 | 15/10/2024 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 15/11/2023 |
Wei He
CEO | Chief Executive Officer | 40 | 23/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 16/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 05/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 01/07/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07/06/24 | Buy | Chief Executive Officer | 60,494 | 0.0015% | ||
| 07/06/24 | Buy | 3,025 | 0.0001% | |||
| 07/06/24 | Buy | Director | 1,210 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +1.78% | -5.68% | -6.90% | 379.72Cr | |
| -1.06% | +2.25% | +23.97% | +113.67% | 10TCr | |
| +1.29% | +1.37% | +48.92% | +152.72% | 5.32TCr | |
| -0.68% | +2.44% | +0.34% | +276.92% | 2.39TCr | |
| +0.60% | +1.63% | -12.87% | -18.47% | 832.1Cr | |
| -1.29% | -4.21% | -35.14% | -36.30% | 764.73Cr | |
| -1.53% | +2.66% | -11.42% | -26.04% | 702.26Cr | |
| -1.14% | -1.47% | +20.50% | +23.29% | 623.04Cr | |
| -1.83% | -0.87% | -0.52% | +22.61% | 540.8Cr | |
| -3.96% | +1.02% | +15.25% | +20.00% | 385.39Cr | |
| Average | -0.99% | +2.88% | +4.34% | +52.15% | 2.21TCr | |
| Weighted average by Cap. | -0.48% | +5.80% | +21.50% | +117.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 17TCr 2.51TCr 2.19TCr 2.03TCr 1.87TCr 3.53TCr 2,40000Cr 3.58TCr 24TCr 9.41TCr 1,19500Cr 9.44TCr 9.23TCr 4,00600Cr | 18TCr 2.66TCr 2.31TCr 2.15TCr 1.98TCr 3.73TCr 2,54100Cr 3.79TCr 25TCr 9.96TCr 1,26500Cr 10TCr 9.78TCr 4,24200Cr |
| Net income | 235.58Cr 35Cr 30Cr 28Cr 26Cr 49Cr 3.33TCr 50Cr 332.63Cr 130.55Cr 1.66TCr 130.98Cr 128.1Cr 5.56TCr | 255.84Cr 38Cr 33Cr 31Cr 28Cr 53Cr 3.62TCr 54Cr 361.24Cr 141.78Cr 1.8TCr 142.25Cr 139.12Cr 6.04TCr |
| Net Debt | -432.08Cr -64Cr -56Cr -52Cr -48Cr -90Cr -6.11TCr -91Cr -610.09Cr -239.44Cr -3.04TCr -240.23Cr -234.96Cr -10TCr | -504.29Cr -75Cr -65Cr -60Cr -55Cr -104.73Cr -7.13TCr -106.36Cr -712.05Cr -279.46Cr -3.55TCr -280.38Cr -274.22Cr -12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | CN¥5.150 | 0.00% | 3,94,74,520 |
| 30/26/30 | CN¥5.150 | +0.59% | 3,74,47,008 |
| 29/26/29 | CN¥5.120 | +1.99% | 3,62,08,510 |
| 28/26/28 | CN¥5.020 | -1.18% | 3,24,64,890 |
| 27/26/27 | CN¥5.080 | +1.40% | 3,09,29,066 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Select your edition
All financial news and data tailored to specific country editions
